Production (Stage)
Phio Pharmaceuticals Corp.
PHIO
$2.96
$0.5020.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.20% | 45.18% | 27.58% | 40.20% | 30.61% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -97.87% | -27.66% | -6.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -71.11% | -41.57% | -84.04% | -68.47% | 221.43% |
| Change in Net Operating Assets | 133.08% | -87.89% | 114.60% | -89.95% | -953.23% |
| Cash from Operations | 42.15% | 32.66% | 35.87% | 25.74% | 12.38% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -43.59% | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00% | -- | -- | 88.89% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.61% | -- | -100.00% | 89.47% | 120,050.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.24% | 123.86% | -178.21% | 26.62% | 101.22% |